Jun 2024 $11 M No. 16 $10 to $50 million 3
Pharmaceutics International, Inc.: Raise no. 16, Jun 2024 × Investors in this round 3 investors had bought by the notice of Oct 23, 2024: 3 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $11 M of $11 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice John E Fowler · Executive Officer, Director David E Solomon · Director James E Gale · Director Mark E Kavulich · Director Michael E Bogda · Director Syed E Abidi, Ph.D. · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Gerard Fleury, Chief Financial Officer. Source: SEC Form D and 1 amendment, newest notice filed Oct 23, 2024. Read the notice at the SEC .
equity SEC Mar 2024 $4 M No. 15 $2 to $10 million 6
Pharmaceutics International, Inc.: Raise no. 15, Mar 2024 × Investors in this round 6 investors had bought by the notice of Mar 13, 2024: 6 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $4 M of $4 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice John E. Fowler · Executive Officer, Director Joseph E. Kiely · Executive Officer David E. Solomon · Director James E. Gale · Director Mark E. Kavulich · Director Michael E. Bogda · Director Syed E. Abidi, Ph.D. · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Joseph Kiely, Chief Financial Officer. Source: SEC Form D, newest notice filed Mar 13, 2024. Read the notice at the SEC .
equity SEC Jun 2023 $6 M No. 14 $2 to $10 million 2
Pharmaceutics International, Inc.: Raise no. 14, Jun 2023 × Investors in this round 2 investors had bought by the notice of Jun 27, 2023: 2 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $6 M of $12 M offered; $6 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice John E. Fowler · Executive Officer, Director Joseph E. Kiely · Executive Officer David E. Solomon · Director James E. Gale · Director Mark E. Kavulich · Director Michael E. Bogda · Director Syed E. Abidi, Ph.D. · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Joseph Kiely, Chief Financial Officer. Source: SEC Form D, newest notice filed Jun 27, 2023. Read the notice at the SEC .
equity SEC Dec 2022 $3 M No. 13 $2 to $10 million 5
Pharmaceutics International, Inc.: Raise no. 13, Dec 2022 × Investors in this round 5 investors had bought by the notice of Dec 12, 2022: 5 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $3 M of $3 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice John E. Fowler · Executive Officer, Director Joseph E. Kiely · Executive Officer David E. Solomon · Director James E. Gale · Director Mark E. Kavulich · Director Michael E. Bogda · Director Syed E. Abidi, Ph.D. · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Joseph Kiely, Chief Financial Officer. Source: SEC Form D, newest notice filed Dec 12, 2022. Read the notice at the SEC .
equity SEC Sep 2022 $9 M No. 12 $2 to $10 million 5
Pharmaceutics International, Inc.: Raise no. 12, Sep 2022 × Investors in this round 5 investors had bought by the notice of Oct 7, 2022: 5 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $9 M of $9 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice John E. Fowler · Executive Officer, Director John E. Guthrie · Executive Officer David E. Solomon · Director James E. Gale · Director Michael I. Bogda · Director Sana I. Abidi · Director Syed E. Abidi, Ph.D. · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by John Guthrie, Chief Financial Officer. Source: SEC Form D, newest notice filed Oct 7, 2022. Read the notice at the SEC .
equity SEC Aug 2022 $5 M No. 11 $2 to $10 million 5
Pharmaceutics International, Inc.: Raise no. 11, Aug 2022 × Investors in this round 5 investors had bought by the notice of Aug 22, 2022: 5 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $5 M of $5 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice John I. Fowler · Executive Officer, Director John I. Guthrie · Executive Officer David E. Solomon · Director James E. Gale · Director Michael N. Bogda · Director Shahab N. Abidi · Director Syed E. Abidi, Ph.D. · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by John Guthrie, Chief Financial Officer. Source: SEC Form D, newest notice filed Aug 22, 2022. Read the notice at the SEC .
equity SEC Jun 2022 $5 M No. 10 $2 to $10 million 5
Pharmaceutics International, Inc.: Raise no. 10, Jun 2022 × Investors in this round 5 investors had bought by the notice of Jul 12, 2022: 5 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $5 M of $5 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice John I. Fowler · Executive Officer, Director John I. Guthrie · Executive Officer David I. Solomon · Director James I. Gale · Director Michael I. Bogda · Director Shahab N. Abidi · Director Syed E. Abidi · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by John Guthrie, Chief Financial Officer. Source: SEC Form D, newest notice filed Jul 12, 2022. Read the notice at the SEC .
equity SEC Mar 2022 $5 M No. 9 $2 to $10 million 4
Pharmaceutics International, Inc.: Raise no. 9, Mar 2022 × Investors in this round 4 investors had bought by the notice of Mar 17, 2022: 4 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $5 M of $5 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice John E. Fowler · Executive Officer, Director John E. Guthrie · Executive Officer David E. Solomon · Director James E. Gale · Director Michael E. Bogda · Director Sana E. Abidi · Director Syed E. Abidi · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by John Guthrie, Chief Financial Officer. Source: SEC Form D, newest notice filed Mar 17, 2022. Read the notice at the SEC .
equity SEC Dec 2021 $5 M No. 8 $2 to $10 million 2
Pharmaceutics International, Inc.: Raise no. 8, Dec 2021 × Investors in this round 2 investors had bought by the notice of Jan 11, 2022: 2 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $5 M of $5 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice John E. Guthrie · Executive Officer Kurt E. Nielsen, Ph.D. · Executive Officer, Director David E. Solomon · Director James E. Gale · Director Michael E. Bogda · Director Sana E. Abidi · Director Syed E. Abidi · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by John Guthrie, Chief Financial Officer. Source: SEC Form D, newest notice filed Jan 11, 2022. Read the notice at the SEC .
equity SEC Oct 2021 $5 M No. 7 $2 to $10 million 2
Pharmaceutics International, Inc.: Raise no. 7, Oct 2021 × Investors in this round 2 investors had bought by the notice of Oct 29, 2021: 2 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $5 M of $5 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice John E. Guthrie · Executive Officer Kurt E. Nielsen, Ph.D. · Executive Officer, Director David E. Solomon · Director George E. Svokos · Director James E. Gale · Director Michael E. Bogda · Director Sana E. Abidi · Director Syed E. Abidi, Ph.D. · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by John Guthrie, Chief Financial Officer. Source: SEC Form D, newest notice filed Oct 29, 2021. Read the notice at the SEC .
equity SEC Jul 2021 $6 M No. 6 $2 to $10 million 5
Pharmaceutics International, Inc.: Raise no. 6, Jul 2021 × Investors in this round 5 investors had bought by the notice of Aug 6, 2021: 5 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $6 M of $6 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice John I. Guthrie · Executive Officer Kurt I. Nielsen, Ph.D. · Executive Officer, Director David I. Solomon · Director George I. Svokos · Director James I. Gale · Director Michael I. Bogda · Director Sana I. Abidi · Director Syed E. Abidi, Ph.D. · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by John Guthrie, Chief Financial Officer. Source: SEC Form D, newest notice filed Aug 6, 2021. Read the notice at the SEC .
equity SEC May 2021 $3 M No. 5 $2 to $10 million 4
Pharmaceutics International, Inc.: Raise no. 5, May 2021 × Investors in this round 4 investors had bought by the notice of Jun 4, 2021: 4 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $3 M of $3 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice John I. Guthrie · Executive Officer Kurt I. Nielsen, Ph.D. · Executive Officer David I. Solomon · Director James I. Gale · Director Michael I. Bogda · Director Sana I. Abidi · Director Syed E. Abidi, Ph.D. · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by John Guthrie, Chief Financial Officer. Source: SEC Form D, newest notice filed Jun 4, 2021. Read the notice at the SEC .
equity SEC Dec 2020 $10 M No. 4 $10 to $50 million 6
Pharmaceutics International, Inc.: Raise no. 4, Dec 2020 × Investors in this round 6 investors had bought by the notice of Jun 4, 2021: 6 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $10 M of $10 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice John I. Guthrie · Executive Officer Kurt I. Nielsen, Ph.D. · Executive Officer David I. Solomon · Director James I. Gale · Director Michael I. Bogda · Director Sana I. Abidi · Director Syed E. Abidi, Ph.D. · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by John Guthrie, Chief Financial Officer. Source: SEC Form D, newest notice filed Jun 4, 2021. Read the notice at the SEC .
equity SEC Oct 2018 $6 M No. 3 $2 to $10 million 5
Pharmaceutics International, Inc.: Raise no. 3, Oct 2018 × Investors in this round 5 investors had bought by the notice of Oct 29, 2018: 5 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $6 M of $15 M offered; $9 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last more than a year
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice John I. Guthrie · Executive Officer Michael E. Bogda · Executive Officer, Director Syed E. Abidi, Ph.D. · Executive Officer, Director David E. Solomon · Director James E. Gale · Director Kevin I. Walsh · Director Sana I. Abidi · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “The amounts reflected above have been rounded to the closest whole number.”Signed by Syed E. Abidi, Ph.D., Chairman and CEO. Source: SEC Form D, newest notice filed Oct 29, 2018. Read the notice at the SEC .
equity SEC Aug 2017 $10 M No. 2 $10 to $50 million 6
Pharmaceutics International, Inc.: Raise no. 2, Aug 2017 × Investors in this round 6 investors had bought by the notice of Aug 15, 2017: 6 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $10 M of $20 M offered; $10 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last more than a year
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Gerard I. Fleury · Executive Officer Julien E. Hecht · Executive Officer Michael E. Bogda · Executive Officer, Director Syed E. Abidi, Ph.D. · Executive Officer, Director David E. Solomon · Director James E. Gale · Director Sana I. Abidi · Director Shahid I. Raza · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Michael Bogda, President. Source: SEC Form D, newest notice filed Aug 15, 2017. Read the notice at the SEC .
equity SEC Aug 2016 $108 M No. 1 $50 to $250 million 9
Pharmaceutics International, Inc.: Raise no. 1, Aug 2016 × Investors in this round 9 investors had bought by the notice of Sep 14, 2016: 9 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $108 M of $108 M offered
Smallest investment taken no minimum stated
What was sold equity, debt Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees $2,574,282
Paid to its own people $9,695,085 (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Jillian E. Dettinger · Executive Officer Julien E. Hecht · Executive Officer Michael E. Bogda · Executive Officer, Director Syed E. Abidi · Executive Officer, Director David E. Solomon · Director James E. Gale · Director Sana I. Abidi · Director Shahid I. Raza · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Teneo Securities LLC (CRD 151256) · New York, New York Sold in NY Remarks in the notice On the amounts: “Total amount sold reflects proceeds consisting of cash and real estate.”Signed by Michael Bogda, President. Source: SEC Form D, newest notice filed Sep 14, 2016. Read the notice at the SEC .
equity, debt SEC